{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:51:06Z","timestamp":1785901866422,"version":"3.56.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00296-020-04639-9","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T19:03:20Z","timestamp":1594753400000},"page":"1539-1554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3224-1151","authenticated-orcid":false,"given":"Sanket","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2121-0942","authenticated-orcid":false,"given":"Debashish","family":"Danda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3643-3989","authenticated-orcid":false,"given":"Chengappa","family":"Kavadichanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3153-4166","authenticated-orcid":false,"given":"Saibal","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8091-1952","authenticated-orcid":false,"given":"M. B.","family":"Adarsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1518-6031","authenticated-orcid":false,"given":"Vir Singh","family":"Negi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"4639_CR1","unstructured":"WHO Coronavirus Disease (COVID-19) Dashboard. https:\/\/covid19.who.int\/?gclid=Cj0KCQjwwr32BRD4ARIsAAJNf_0jdmZQ1hkz7onImyjahwc-N0H4WTwXnVU7bgQObfk_Vct9yucybbkaAk0oEALw_wcB. Accessed 28 May 2020"},{"key":"4639_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104327","author":"TMA El-Aziz","year":"2020","unstructured":"El-Aziz TMA, Stockand JD (2020) Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status. Infect Genet Evol. https:\/\/doi.org\/10.1016\/j.meegid.2020.104327","journal-title":"Infect Genet Evol"},{"key":"4639_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0311-8","author":"MZ Tay","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LFP (2020) The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. https:\/\/doi.org\/10.1038\/s41577-020-0311-8","journal-title":"Nat Rev Immunol"},{"key":"4639_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31103-X","author":"L Verdoni","year":"2020","unstructured":"Verdoni L, Mazza A, Gervasoni A et al (2020) An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet Lond Engl. https:\/\/doi.org\/10.1016\/S0140-6736(20)31103-X","journal-title":"Lancet Lond Engl"},{"key":"4639_CR5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2009191","author":"G Toscano","year":"2020","unstructured":"Toscano G, Palmerini F, Ravaglia S et al (2020) Guillain-Barr\u00e9 Syndrome associated with SARS-CoV-2. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMc2009191","journal-title":"N Engl J Med"},{"issue":"4","key":"4639_CR6","doi-asserted-by":"publisher","first-page":"e741","DOI":"10.1212\/NXI.0000000000000741","volume":"7","author":"P Alberti","year":"2020","unstructured":"Alberti P, Beretta S, Piatti M et al (2020) Guillain-Barr\u00e9 syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflammation 7(4):e741. https:\/\/doi.org\/10.1212\/NXI.0000000000000741","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"4639_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30082-5","author":"The Lancet Rheumatology","year":"2020","unstructured":"The Lancet Rheumatology (2020) Unity amidst uncertainty: COVID-19 pandemic fosters collaboration in rheumatology community. Lancet Rheumatol. https:\/\/doi.org\/10.1016\/S2665-9913(20)30082-5","journal-title":"Lancet Rheumatol"},{"key":"4639_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05073-9","author":"DP Misra","year":"2020","unstructured":"Misra DP, Agarwal V, Gasparyan AY, Zimba O (2020) Rheumatologists\u2019 perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol. https:\/\/doi.org\/10.1007\/s10067-020-05073-9","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4639_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-020-0160-6","volume":"6","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brahmer JR, Callahan MK et al (2020) Immune-related adverse events of checkpoint inhibitors. Nat Rev Dis Primer 6(1):1\u201321. https:\/\/doi.org\/10.1038\/s41572-020-0160-6","journal-title":"Nat Rev Dis Primer"},{"issue":"6","key":"4639_CR10","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1136\/annrheumdis-2018-214748","volume":"78","author":"M Kostine","year":"2019","unstructured":"Kostine M, Cappelli LC, Calabrese C et al (2019) Addressing immune-related adverse events of cancer immunotherapy: how prepared are rheumatologists? Ann Rheum Dis 78(6):860\u2013862. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214748","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4639_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1042\/CS20200163","volume":"134","author":"D Batlle","year":"1979","unstructured":"Batlle D, Wysocki J (1979) Satchell K (2020) Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Clin Sci Lond Engl 134(5):543\u2013545. https:\/\/doi.org\/10.1042\/CS20200163","journal-title":"Clin Sci Lond Engl"},{"issue":"2","key":"4639_CR12","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203(2):631\u2013637. https:\/\/doi.org\/10.1002\/path.1570","journal-title":"J Pathol"},{"issue":"13","key":"4639_CR13","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM (2020) Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 323(13):1239\u20131242. https:\/\/doi.org\/10.1001\/jama.2020.2648","journal-title":"JAMA"},{"key":"4639_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa330","author":"A Giacomelli","year":"2020","unstructured":"Giacomelli A, Pezzati L, Conti F et al (2020) Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa330","journal-title":"Clin Infect Dis"},{"key":"4639_CR15","doi-asserted-by":"publisher","DOI":"10.7326\/M20-2428","author":"JR Lechien","year":"2020","unstructured":"Lechien JR, Chiesa-Estomba CM, Hans S, Barillari MR, Jouffe L, Saussez S (2020) Loss of smell and taste in 2013 European patients with mild to moderate COVID-19. Ann Intern Med. https:\/\/doi.org\/10.7326\/M20-2428","journal-title":"Ann Intern Med"},{"issue":"6","key":"4639_CR16","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1136\/gutjnl-2020-320926","volume":"69","author":"X Jin","year":"2020","unstructured":"Jin X, Lian J-S, Hu J-H et al (2020) Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 69(6):1002\u20131009. https:\/\/doi.org\/10.1136\/gutjnl-2020-320926","journal-title":"Gut"},{"issue":"24","key":"4639_CR17","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1056\/NEJMc2010419","volume":"382","author":"P Goyal","year":"2020","unstructured":"Goyal P, Choi JJ, Pinheiro LC et al (2020) Clinical characteristics of Covid-19 in New York City. N Engl J Med 382(24):2372\u20132374. https:\/\/doi.org\/10.1056\/NEJMc2010419","journal-title":"N Engl J Med"},{"issue":"5","key":"4639_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1001\/jamaophthalmol.2020.1291","volume":"138","author":"P Wu","year":"2020","unstructured":"Wu P, Duan F, Luo C et al (2020) Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province. China JAMA Ophthalmol 138(5):575\u2013578. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.1291","journal-title":"China JAMA Ophthalmol"},{"key":"4639_CR19","unstructured":"CDC Coronavirus Disease 2019 (COVID-19) Centers for Disease Control and Prevention (2020). https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html"},{"issue":"5","key":"4639_CR20","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1016\/S2665-9913(20)30095-3","volume":"2","author":"MA Gianfrancesco","year":"2020","unstructured":"Gianfrancesco MA, Hyrich KL, Gossec L et al (2020) Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. Lancet Rheumatol 2(5):e250\u2013e253. https:\/\/doi.org\/10.1016\/S2665-9913(20)30095-3","journal-title":"Lancet Rheumatol"},{"key":"4639_CR21","unstructured":"Overview of Public Health and Social Measures in the context of COVID-19. https:\/\/www.who.int\/publications-detail-redirect\/overview-of-public-health-and-social-measures-in-the-context-of-covid-19"},{"key":"4639_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217573","author":"M Beydon","year":"2020","unstructured":"Beydon M, Chevalier K, Tabaa OA et al (2020) Myositis as a manifestation of SARS-CoV-2. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217573","journal-title":"Ann Rheum Dis"},{"key":"4639_CR23","unstructured":"Casas CG, Catal\u00e0 A, Hern\u00e1ndez GC, et al (2020) Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 10.1111\/bjd.19163"},{"issue":"20","key":"4639_CR24","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1056\/NEJMc2009787","volume":"382","author":"TJ Oxley","year":"2020","unstructured":"Oxley TJ, Mocco J, Majidi S et al (2020) Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 382(20):e60. https:\/\/doi.org\/10.1056\/NEJMc2009787","journal-title":"N Engl J Med"},{"key":"4639_CR25","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1096","author":"RM Inciardi","year":"2020","unstructured":"Inciardi RM, Lupi L, Zaccone G et al (2020) Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2020.1096","journal-title":"JAMA Cardiol"},{"issue":"19","key":"4639_CR26","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/eurheartj\/ehaa288","volume":"41","author":"I-C Kim","year":"2020","unstructured":"Kim I-C, Kim JY, Kim HA, Han S (2020) COVID-19-related myocarditis in a 21-year-old female patient. Eur Heart J 41(19):1859\u20131859. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa288","journal-title":"Eur Heart J"},{"issue":"10229","key":"4639_CR27","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033\u20131034. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet"},{"key":"4639_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05180-7","author":"C Gazzaruso","year":"2020","unstructured":"Gazzaruso C, Carlo Stella N, Mariani G et al (2020) High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia. Clin Rheumatol. https:\/\/doi.org\/10.1007\/s10067-020-05180-7","journal-title":"Clin Rheumatol"},{"key":"4639_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14867","author":"I Harzallah","year":"2020","unstructured":"Harzallah I, Debliquis A, Dr\u00e9nou B (2020) Lupus anticoagulant is frequent in patients with Covid-19. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.14867","journal-title":"J Thromb Haemost"},{"issue":"17","key":"4639_CR30","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1056\/NEJMc2007575","volume":"382","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xiao M, Zhang S et al (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 382(17):e38. https:\/\/doi.org\/10.1056\/NEJMc2007575","journal-title":"N Engl J Med"},{"issue":"10229","key":"4639_CR31","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet Lond Engl 395(10229):1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet Lond Engl"},{"issue":"2","key":"4639_CR32","first-page":"198","volume":"28","author":"S Esposito","year":"2020","unstructured":"Esposito S, Noviello S, Pagliano P (2020) Update on treatment of COVID-19: ongoing studies between promising and disappointing results. Infez Med 28(2):198\u2013211","journal-title":"Infez Med"},{"issue":"3","key":"4639_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/ard.2004.023200","volume":"65","author":"E Casado","year":"2006","unstructured":"Casado E, Gratac\u00f3s J, Tolosa C et al (2006) Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients. Ann Rheum Dis 65(3):385\u2013390. https:\/\/doi.org\/10.1136\/ard.2004.023200","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4639_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/QCO.0000000000000532","volume":"32","author":"FG Hayden","year":"2019","unstructured":"Hayden FG, Shindo N (2019) Influenza virus polymerase inhibitors in clinical development. Curr Opin Infect Dis 32(2):176\u2013186. https:\/\/doi.org\/10.1097\/QCO.0000000000000532","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"4639_CR35","first-page":"1023","volume":"4","author":"A Chandwani","year":"2008","unstructured":"Chandwani A, Shuter J (2008) Lopinavir\/ritonavir in the treatment of HIV-1 infection: a review. Ther Clin Risk Manag 4(5):1023\u20131033","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"4639_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0973-6883(12)60090-5","volume":"2","author":"GS Naik","year":"2012","unstructured":"Naik GS, Tyagi MG (2012) A pharmacological profile of ribavirin and monitoring of its plasma concentration in Chronic Hepatitis C Infection. J Clin Exp Hepatol 2(1):42\u201354. https:\/\/doi.org\/10.1016\/S0973-6883(12)60090-5","journal-title":"J Clin Exp Hepatol"},{"issue":"10","key":"4639_CR37","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1093\/rheumatology\/kew431","volume":"56","author":"A Psarras","year":"2017","unstructured":"Psarras A, Emery P, Vital EM (2017) Type I interferon\u2013mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy. Rheumatology 56(10):1662\u20131675. https:\/\/doi.org\/10.1093\/rheumatology\/kew431","journal-title":"Rheumatology"},{"issue":"4","key":"4639_CR38","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18(4):844\u2013847. https:\/\/doi.org\/10.1111\/jth.14768","journal-title":"J Thromb Haemost"},{"key":"4639_CR39","doi-asserted-by":"publisher","DOI":"10.7326\/M20-2003","author":"D Wichmann","year":"2020","unstructured":"Wichmann D, Sperhake J-P, L\u00fctgehetmann M et al (2020) Autopsy findings and venous thromboembolism in patients With COVID-19. Ann Intern Med. https:\/\/doi.org\/10.7326\/M20-2003","journal-title":"Ann Intern Med"},{"key":"4639_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30145-9","author":"M Levi","year":"2020","unstructured":"Levi M, Thachil J, Iba T, Levy JH (2020) Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. https:\/\/doi.org\/10.1016\/S2352-3026(20)30145-9","journal-title":"Lancet Haematol"},{"key":"4639_CR41","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1712155","author":"J Thachil","year":"2020","unstructured":"Thachil J, Srivastava A (2020) SARS-2 coronavirus-associated hemostatic lung abnormality in COVID-19: is it pulmonary thrombosis or pulmonary embolism? Semin Thromb Hemost. https:\/\/doi.org\/10.1055\/s-0040-1712155","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"4639_CR42","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/MBC.0000000000000065","volume":"25","author":"M Stockschlaeder","year":"2014","unstructured":"Stockschlaeder M, Schneppenheim R, Budde U (2014) Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis. Blood Coagul Fibrinolysis Int J Haemost Thromb 25(3):206\u2013216. https:\/\/doi.org\/10.1097\/MBC.0000000000000065","journal-title":"Blood Coagul Fibrinolysis Int J Haemost Thromb"},{"key":"4639_CR43","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.30.20086736","author":"Y Zuo","year":"2020","unstructured":"Zuo Y, Zuo M, Yalavarthi S et al (2020) Neutrophil extracellular traps and thrombosis in COVID-19. MedRxiv. https:\/\/doi.org\/10.1101\/2020.04.30.20086736","journal-title":"MedRxiv"},{"issue":"5","key":"4639_CR44","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Bai H, Chen X, Gong J, Li D, Sun Z (2020) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 18(5):1094\u20131099. https:\/\/doi.org\/10.1111\/jth.14817","journal-title":"J Thromb Haemost"},{"issue":"4","key":"4639_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0167-5699(89)90245-4","volume":"10","author":"Y Shoenfeld","year":"1989","unstructured":"Shoenfeld Y, Isenberg DA (1989) The mosaic of autoimmunity. Immunol Today 10(4):123\u2013126. https:\/\/doi.org\/10.1016\/0167-5699(89)90245-4","journal-title":"Immunol Today"},{"key":"4639_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00243","author":"MI Arleevskaya","year":"2017","unstructured":"Arleevskaya MI, Manukyan G, Inoue R, Aminov R (2017) Editorial: microbial and environmental factors in autoimmune and inflammatory diseases. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2017.00243","journal-title":"Front Immunol"},{"issue":"1","key":"4639_CR47","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1749-6632.2009.04759.x","volume":"1173","author":"N Toplak","year":"2009","unstructured":"Toplak N, Av\u010din T (2009) Influenza and autoimmunity. Ann N Y Acad Sci 1173(1):619\u2013626. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04759.x","journal-title":"Ann N Y Acad Sci"},{"key":"4639_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00116","author":"Y Acosta-Ampudia","year":"2018","unstructured":"Acosta-Ampudia Y, Monsalve DM, Castillo-Medina LF et al (2018) Autoimmune neurological conditions associated with zika virus infection. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2018.00116","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"4639_CR49","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/BOR.0000000000000396","volume":"29","author":"A Tanay","year":"2017","unstructured":"Tanay A (2017) Chikungunya virus and autoimmunity. Curr Opin Rheumatol 29(4):389\u2013393. https:\/\/doi.org\/10.1097\/BOR.0000000000000396","journal-title":"Curr Opin Rheumatol"},{"key":"4639_CR50","doi-asserted-by":"publisher","first-page":"42147","DOI":"10.1038\/srep42147","volume":"7","author":"H Fausther-Bovendo","year":"2017","unstructured":"Fausther-Bovendo H, Qiu X, McCorrister S et al (2017) Ebola virus infection induces autoimmunity against dsDNA and HSP60. Sci Rep 7:42147. https:\/\/doi.org\/10.1038\/srep42147","journal-title":"Sci Rep"},{"issue":"1","key":"4639_CR51","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","volume":"19","author":"RS Fujinami","year":"2006","unstructured":"Fujinami RS, von Herrath MG, Christen U, Whitton JL (2006) Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 19(1):80\u201394. https:\/\/doi.org\/10.1128\/CMR.19.1.80-94.2006","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"4639_CR52","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/v11080762","volume":"11","author":"MK Smatti","year":"2019","unstructured":"Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM (2019) Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses 11(8):762. https:\/\/doi.org\/10.3390\/v11080762","journal-title":"Viruses"},{"issue":"1","key":"4639_CR53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/08916930500484708","volume":"39","author":"B Kim","year":"2006","unstructured":"Kim B, Kaistha SD, Rouse BT (2006) Viruses and autoimmunity. Autoimmunity 39(1):71\u201377. https:\/\/doi.org\/10.1080\/08916930500484708","journal-title":"Autoimmunity"},{"issue":"1","key":"4639_CR54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12016-011-8294-7","volume":"42","author":"MF Cusick","year":"2012","unstructured":"Cusick MF, Libbey JE, Fujinami RS (2012) Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol 42(1):102\u2013111. https:\/\/doi.org\/10.1007\/s12016-011-8294-7","journal-title":"Clin Rev Allergy Immunol"},{"key":"4639_CR55","doi-asserted-by":"publisher","first-page":"100051","DOI":"10.1016\/j.jtauto.2020.100051","volume":"3","author":"J Lyons-Weiler","year":"2020","unstructured":"Lyons-Weiler J (2020) Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity. J Transl Autoimmun 3:100051. https:\/\/doi.org\/10.1016\/j.jtauto.2020.100051","journal-title":"J Transl Autoimmun"},{"key":"4639_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217522","author":"S Megremis","year":"2020","unstructured":"Megremis S, Walker TDJ, He X et al (2020) Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217522","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4639_CR57","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.coviro.2012.04.004","volume":"2","author":"AL Totura","year":"2012","unstructured":"Totura AL, Baric RS (2012) SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. Curr Opin Virol 2(3):264\u2013275. https:\/\/doi.org\/10.1016\/j.coviro.2012.04.004","journal-title":"Curr Opin Virol"},{"key":"4639_CR58","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00510-20","author":"A Nguyen","year":"2020","unstructured":"Nguyen A, David JK, Maden SK et al (2020) Human leukocyte antigen susceptibility map for SARS-CoV-2. J Virol. https:\/\/doi.org\/10.1128\/JVI.00510-20","journal-title":"J Virol"},{"issue":"1","key":"4639_CR59","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000501896","volume":"29","author":"A Charfi","year":"2020","unstructured":"Charfi A, Mahfoudh N, Kamoun A et al (2020) Association of HLA Alleles with Primary Sj\u00f6gren Syndrome in the South Tunisian Population. Med Princ Pract 29(1):32\u201338. https:\/\/doi.org\/10.1159\/000501896","journal-title":"Med Princ Pract"},{"issue":"2","key":"4639_CR60","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0198-8859(00)00249-4","volume":"62","author":"F Choukri","year":"2001","unstructured":"Choukri F, Chakib A, Himmich H, H\u00fce S, Caillat-Zucman S (2001) HLA-B\u221751 and B\u221715 alleles confer predisposition to Beh\u00e7et\u2019s disease in Moroccan patients. Hum Immunol 62(2):180\u2013185. https:\/\/doi.org\/10.1016\/S0198-8859(00)00249-4","journal-title":"Hum Immunol"},{"issue":"1","key":"4639_CR61","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1600-065X.1998.tb01207.x","volume":"164","author":"PV Lehmann","year":"1998","unstructured":"Lehmann PV, Targoni OS, Forsthuber TG (1998) Shifting T-cell activation thresholds in autoimmunity and determinant spreading. Immunol Rev 164(1):53\u201361. https:\/\/doi.org\/10.1111\/j.1600-065X.1998.tb01207.x","journal-title":"Immunol Rev"},{"key":"4639_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035296","author":"J Sokolove","year":"2012","unstructured":"Sokolove J, Bromberg R, Deane KD et al (2012) Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0035296","journal-title":"PLoS ONE"},{"issue":"1","key":"4639_CR63","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1749-6632.2003.tb06036.x","volume":"987","author":"US Deshmukh","year":"2003","unstructured":"Deshmukh US, Gaskin F, Lewis JE, Kannapell CC, Fu SM (2003) Mechanisms of autoantibody diversification to SLE-related autoantigens. Ann N Y Acad Sci 987(1):91\u201398. https:\/\/doi.org\/10.1111\/j.1749-6632.2003.tb06036.x","journal-title":"Ann N Y Acad Sci"},{"issue":"16","key":"4639_CR64","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"MR Arbuckle","year":"2003","unstructured":"Arbuckle MR, McClain MT, Rubertone MV et al (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349(16):1526\u20131533. https:\/\/doi.org\/10.1056\/NEJMoa021933","journal-title":"N Engl J Med"},{"issue":"7","key":"4639_CR65","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nm0798-781","volume":"4","author":"MS Horwitz","year":"1998","unstructured":"Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvennick N (1998) Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry. Nat Med 4(7):781\u2013785. https:\/\/doi.org\/10.1038\/nm0798-781","journal-title":"Nat Med"},{"issue":"1","key":"4639_CR66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/08916930500484799","volume":"39","author":"L McCoy","year":"2006","unstructured":"McCoy L, Tsunoda I, Fujinami RS (2006) Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity 39(1):9\u201319. https:\/\/doi.org\/10.1080\/08916930500484799","journal-title":"Autoimmunity"},{"issue":"11","key":"4639_CR67","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.4049\/jimmunol.158.11.5283","volume":"158","author":"K Ando","year":"1997","unstructured":"Ando K, Hiroishi K, Kaneko T et al (1997) Perforin, Fas\/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol 158(11):5283\u20135291","journal-title":"J Immunol"},{"issue":"5","key":"4639_CR68","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","volume":"80","author":"KW Wucherpfennig","year":"1995","unstructured":"Wucherpfennig KW, Strominger JL (1995) Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80(5):695\u2013705. https:\/\/doi.org\/10.1016\/0092-8674(95)90348-8","journal-title":"Cell"},{"issue":"2","key":"4639_CR69","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/01.md.0000157397.30055.c9","volume":"84","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Loustaud-Ratti V, De Vita S et al (2005) Sj\u00f6gren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 84(2):81\u201389. https:\/\/doi.org\/10.1097\/01.md.0000157397.30055.c9","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"4639_CR70","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s100670050064","volume":"18","author":"M Ramos-Casals","year":"1999","unstructured":"Ramos-Casals M, Garc\u00eda-Carrasco M, Cervera R, Font J (1999) Sj\u00f6gren\u2019s syndrome and hepatitis C virus. Clin Rheumatol 18(2):93\u2013100. https:\/\/doi.org\/10.1007\/s100670050064","journal-title":"Clin Rheumatol"},{"issue":"5","key":"4639_CR71","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","volume":"17","author":"M Zheng","year":"2020","unstructured":"Zheng M, Gao Y, Wang G et al (2020) Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol 17(5):533\u2013535. https:\/\/doi.org\/10.1038\/s41423-020-0402-2","journal-title":"Cell Mol Immunol"},{"issue":"10223","key":"4639_CR72","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China The Lancet 395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"China The Lancet"},{"issue":"7","key":"4639_CR73","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.3346\/jkms.2020.35.e86","volume":"35","author":"JY Kim","year":"2020","unstructured":"Kim JY, Ko JH, Kim Y et al (2020) Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea. J Korean Med Sci 35(7):e86. https:\/\/doi.org\/10.3346\/jkms.2020.35.e86","journal-title":"J Korean Med Sci"},{"key":"4639_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102597","author":"M Ehrenfeld","year":"2020","unstructured":"Ehrenfeld M, Tincani A, Andreoli L et al (2020) Covid-19 and autoimmunity. Autoimmun Rev. https:\/\/doi.org\/10.1016\/j.autrev.2020.102597","journal-title":"Autoimmun Rev"},{"key":"4639_CR75","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/JIR.S70325","volume":"8","author":"MJ Podolska","year":"2015","unstructured":"Podolska MJ, Biermann MH, Mauer\u00f6der C, Hahn J, Herrmann M (2015) Inflammatory etiopathogenesis of systemic lupus erythematosus: an update. J Inflamm Res 8:161\u2013171. https:\/\/doi.org\/10.2147\/JIR.S70325","journal-title":"J Inflamm Res"},{"issue":"2","key":"4639_CR76","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1128\/JVI.56.2.651-654.1985","volume":"56","author":"D Matteucci","year":"1985","unstructured":"Matteucci D, Paglianti M, Giangregorio AM, Capobianchi MR, Dianzani F, Bendinelli M (1985) Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines. J Virol 56(2):651\u2013654","journal-title":"J Virol"},{"issue":"5","key":"4639_CR77","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/emboj\/21.5.954","volume":"21","author":"A Nanbo","year":"2002","unstructured":"Nanbo A, Inoue K, Adachi-Takasawa K, Takada K (2002) Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt\u2019s lymphoma. EMBO J 21(5):954\u2013965. https:\/\/doi.org\/10.1093\/emboj\/21.5.954","journal-title":"EMBO J"},{"issue":"8","key":"4639_CR78","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","volume":"14","author":"E de Wit","year":"2016","unstructured":"de Wit E, van Doremalen N, Falzarano D, Munster VJ (2016) SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 14(8):523\u2013534. https:\/\/doi.org\/10.1038\/nrmicro.2016.81","journal-title":"Nat Rev Microbiol"},{"key":"4639_CR79","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138999","author":"Y Zuo","year":"2020","unstructured":"Zuo Y, Yalavarthi S, Shi H et al (2020) Neutrophil extracellular traps in COVID-19. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.138999","journal-title":"JCI Insight"},{"issue":"2","key":"4639_CR80","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos V (2018) Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol 18(2):134\u2013147. https:\/\/doi.org\/10.1038\/nri.2017.105","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"4639_CR81","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41584-019-0352-1","volume":"16","author":"G Wigerblad","year":"2020","unstructured":"Wigerblad G, Kaplan MJ (2020) NETs spread ever wider in rheumatic diseases. Nat Rev Rheumatol 16(2):73\u201374. https:\/\/doi.org\/10.1038\/s41584-019-0352-1","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"4639_CR82","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan. China JAMA 323(11):1061\u20131069. https:\/\/doi.org\/10.1001\/jama.2020.1585","journal-title":"China JAMA"},{"issue":"3","key":"4639_CR83","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1083\/jcb.201006052","volume":"191","author":"V Papayannopoulos","year":"2010","unstructured":"Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A (2010) Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 191(3):677\u2013691. https:\/\/doi.org\/10.1083\/jcb.201006052","journal-title":"J Cell Biol"},{"key":"4639_CR84","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1628","author":"KH Chan","year":"2020","unstructured":"Chan KH, Lee P, Chan CY, Lam KBH, Ho P (2020) Monitoring respiratory infections in covid-19 epidemics. BMJ. https:\/\/doi.org\/10.1136\/bmj.m1628","journal-title":"BMJ"},{"key":"4639_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16224515","author":"MG Baker","year":"2019","unstructured":"Baker MG, Gurney J, Oliver J et al (2019) Risk factors for acute rheumatic fever: literature review and protocol for a case-control study in New Zealand. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph16224515","journal-title":"Int J Environ Res Public Health"},{"key":"4639_CR86","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/ITT.S61528","volume":"4","author":"LT Stiemsma","year":"2015","unstructured":"Stiemsma LT, Reynolds LA, Turvey SE, Finlay BB (2015) The hygiene hypothesis: current perspectives and future therapies. Immunotargets Ther 4:143\u2013157. https:\/\/doi.org\/10.2147\/ITT.S61528","journal-title":"Immunotargets Ther"},{"issue":"2","key":"4639_CR87","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nri.2017.111","volume":"18","author":"J-F Bach","year":"2018","unstructured":"Bach J-F (2018) The hygiene hypothesis in autoimmunity: the role of pathogens and commensals. Nat Rev Immunol 18(2):105\u2013120. https:\/\/doi.org\/10.1038\/nri.2017.111","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"4639_CR88","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/annrheumdis-2019-216631","volume":"79","author":"J Manasson","year":"2020","unstructured":"Manasson J, Blank RB, Scher JU (2020) The microbiome in rheumatology: where are we and where should we go? Ann Rheum Dis 79(6):727\u2013733. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216631","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4639_CR89","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.autrev.2007.11.007","volume":"7","author":"L Stojanovich","year":"2008","unstructured":"Stojanovich L, Marisavljevich D (2008) Stress as a trigger of autoimmune disease. Autoimmun Rev 7(3):209\u2013213. https:\/\/doi.org\/10.1016\/j.autrev.2007.11.007","journal-title":"Autoimmun Rev"},{"issue":"5","key":"4639_CR90","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","volume":"19","author":"TT Le","year":"2020","unstructured":"Le TT, Andreadakis Z, Kumar A et al (2020) The COVID-19 vaccine development landscape. Nat Rev Drug Discov 19(5):305\u2013306. https:\/\/doi.org\/10.1038\/d41573-020-00073-5","journal-title":"Nat Rev Drug Discov"},{"issue":"294","key":"4639_CR91","doi-asserted-by":"publisher","first-page":"294ra105","DOI":"10.1126\/scitranslmed.aab2354","volume":"7","author":"SS Ahmed","year":"2015","unstructured":"Ahmed SS, Volkmuth W, Duca J et al (2015) Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med 7(294):294ra105. https:\/\/doi.org\/10.1126\/scitranslmed.aab2354","journal-title":"Sci Transl Med"},{"issue":"9","key":"4639_CR92","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1080\/21645515.2016.1177688","volume":"12","author":"AS Agrawal","year":"2016","unstructured":"Agrawal AS, Tao X, Algaissi A et al (2016) Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus. Hum Vaccines Immunother 12(9):2351\u20132356. https:\/\/doi.org\/10.1080\/21645515.2016.1177688","journal-title":"Hum Vaccines Immunother"},{"issue":"12","key":"4639_CR93","doi-asserted-by":"publisher","first-page":"e525","DOI":"10.1371\/journal.pmed.0030525","volume":"3","author":"D Deming","year":"2006","unstructured":"Deming D, Sheahan T, Heise M et al (2006) Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants. PLoS Med 3(12):e525. https:\/\/doi.org\/10.1371\/journal.pmed.0030525","journal-title":"PLoS Med"},{"issue":"4","key":"4639_CR94","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jmv.25685","volume":"92","author":"G Li","year":"2020","unstructured":"Li G, Fan Y, Lai Y et al (2020) Coronavirus infections and immune responses. J Med Virol 92(4):424\u2013432. https:\/\/doi.org\/10.1002\/jmv.25685","journal-title":"J Med Virol"},{"key":"4639_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2020.03.012","author":"HK Siddiqi","year":"2020","unstructured":"Siddiqi HK, Mehra MR (2020) COVID-19 Illness in Native and Immunosuppressed States: a clinical-therapeutic staging proposal. J Heart Lung Transpl. https:\/\/doi.org\/10.1016\/j.healun.2020.03.012","journal-title":"J Heart Lung Transpl"},{"issue":"12","key":"4639_CR96","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1007\/s10067-018-4095-1","volume":"37","author":"HE S\u00f6nmez","year":"2018","unstructured":"S\u00f6nmez HE, Demir S, Bilginer Y, \u00d6zen S (2018) Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature. Clin Rheumatol 37(12):3329\u20133335. https:\/\/doi.org\/10.1007\/s10067-018-4095-1","journal-title":"Clin Rheumatol"},{"key":"4639_CR97","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1200\/EDBK_238691","volume":"39","author":"B Santomasso","year":"2019","unstructured":"Santomasso B, Bachier C, Westin J, Rezvani K, Shpall EJ (2019) The other side of CAR T-Cell therapy: cytokine release syndrome, neurologic toxicity, and financial burden. Am Soc Clin Oncol Educ Book 39:433\u2013444. https:\/\/doi.org\/10.1200\/EDBK_238691","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"4639_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30164-8","author":"T Huet","year":"2020","unstructured":"Huet T, Beaussier H, Voisin O et al (2020) Anakinra for severe forms of COVID-19: a cohort study. Lancet Rheumatol. https:\/\/doi.org\/10.1016\/S2665-9913(20)30164-8","journal-title":"Lancet Rheumatol"},{"issue":"6","key":"4639_CR99","doi-asserted-by":"publisher","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","volume":"19","author":"D McGonagle","year":"2020","unstructured":"McGonagle D, Sharif K, O\u2019Regan A, Bridgewood C (2020) The role of cytokines including Interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev 19(6):102537. https:\/\/doi.org\/10.1016\/j.autrev.2020.102537","journal-title":"Autoimmun Rev"},{"key":"4639_CR100","doi-asserted-by":"publisher","first-page":"5656320","DOI":"10.1155\/2016\/5656320","volume":"2016","author":"E Watanabe","year":"2016","unstructured":"Watanabe E, Sugawara H, Yamashita T, Ishii A, Oda A, Terai C (2016) Successful tocilizumab therapy for macrophage activation syndrome associated with adult-onset still\u2019s disease: a case-based review. Case Rep Med 2016:5656320. https:\/\/doi.org\/10.1155\/2016\/5656320","journal-title":"Case Rep Med"},{"issue":"20","key":"4639_CR101","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","volume":"117","author":"X Xu","year":"2020","unstructured":"Xu X, Han M, Li T et al (2020) Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci 117(20):10970\u201310975. https:\/\/doi.org\/10.1073\/pnas.2005615117","journal-title":"Proc Natl Acad Sci"},{"key":"4639_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.04.017","author":"F Cantini","year":"2020","unstructured":"Cantini F, Niccoli L, Matarrese D, Nicastri E, Stobbione P, Goletti D (2020) Baricitinib therapy in COVID-19: a pilot study on safety and clinical impact. J Infect. https:\/\/doi.org\/10.1016\/j.jinf.2020.04.017","journal-title":"J Infect"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04639-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04639-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04639-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T07:13:34Z","timestamp":1696403614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04639-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":102,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4639"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04639-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"assertion":[{"value":"3 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}